Creative Planning’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-325
| Closed | -$2.78K | – | 3498 |
|
|
2024
Q4 | $2.78K | Hold |
325
| – | – | ﹤0.01% | 3444 |
|
|
2024
Q3 | $6.96K | Sell |
325
-2
| -0.6% | -$55 | ﹤0.01% | 3177 |
|
|
2024
Q2 | $7.46K | Buy |
327
+2
| +0.6% | +$54 | ﹤0.01% | 3021 |
|
|
2024
Q1 | $14.5K | Sell |
325
-40
| -11% | -$2.01K | ﹤0.01% | 2853 |
|
|
2023
Q4 | $22.9K | Hold |
365
| – | – | ﹤0.01% | 2690 |
|
|
2023
Q3 | $26.5K | Hold |
365
| – | – | ﹤0.01% | 2561 |
|
|
2023
Q2 | $23.3K | Hold |
365
| – | – | ﹤0.01% | 2497 |
|
|
2023
Q1 | $12.9K | Hold |
365
| – | – | ﹤0.01% | 2447 |
|
|
2022
Q4 | $8.6K | Hold |
365
| – | – | ﹤0.01% | 2365 |
|
|
2022
Q3 | $13K | Hold |
365
| – | – | ﹤0.01% | 2207 |
|
|
2022
Q2 | $19K | Hold |
365
| – | – | ﹤0.01% | 2150 |
|
|
2022
Q1 | $25K | Hold |
365
| – | – | ﹤0.01% | 2117 |
|
|
2021
Q4 | $30K | Hold |
365
| – | – | ﹤0.01% | 2025 |
|
|
2021
Q3 | $40K | Hold |
365
| – | – | ﹤0.01% | 2014 |
|
|
2021
Q2 | $41K | Hold |
365
| – | – | ﹤0.01% | 1954 |
|
|
2021
Q1 | $41K | Buy |
365
+40
| +12% | +$4.81K | ﹤0.01% | 2372 |
|
|
2020
Q4 | $33K | Sell |
325
-15
| -4% | -$1.31K | ﹤0.01% | 2141 |
|
|
2020
Q3 | $22K | Buy |
340
+50
| +17% | +$3.78K | ﹤0.01% | 1971 |
|
|
2020
Q2 | $20K | Buy |
+290
| New | +$19.8K | ﹤0.01% | 1828 |
|
|
2019
Q3 | – | Sell |
-17
| Closed | -$4K | – | 2004 |
|
|
2019
Q2 | $4K | Hold |
17
| – | – | ﹤0.01% | 1960 |
|
|
2019
Q1 | $4K | Hold |
17
| – | – | ﹤0.01% | 1914 |
|
|
2018
Q4 | $4K | Hold |
17
| – | – | ﹤0.01% | 1871 |
|
|
2018
Q3 | $11K | Sell |
17
-33
| -66% | -$18.2K | ﹤0.01% | 1983 |
|
|
2018
Q2 | $27K | Hold |
50
| – | – | ﹤0.01% | 1890 |
|
|
2018
Q1 | $26K | Buy |
50
+33
| +194% | +$20.2K | ﹤0.01% | 1868 |
|
|
2017
Q4 | $11K | Hold |
17
| – | – | ﹤0.01% | 1880 |
|
|
2017
Q3 | $11K | Hold |
17
| – | – | ﹤0.01% | 1854 |
|
|
2017
Q2 | $8K | Hold |
17
| – | – | ﹤0.01% | 3732 |
|
|
2017
Q1 | $10K | Hold |
17
| – | – | ﹤0.01% | 3578 |
|
|
2016
Q4 | $9K | Hold |
17
| – | – | ﹤0.01% | 3595 |
|
|
2016
Q3 | $12K | Sell |
17
-8
| -32% | -$4.26K | ﹤0.01% | 3371 |
|
|
2016
Q2 | $12K | Hold |
25
| – | – | ﹤0.01% | 3115 |
|
|
2016
Q1 | $15K | Sell |
25
-13
| -34% | -$8.17K | ﹤0.01% | 2946 |
|
|
2015
Q4 | $30K | Buy |
+38
| New | +$31.5K | ﹤0.01% | 2519 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3629 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 3325 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3212 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 3067 |
|
Other funds holding BLRX
NRG
NA
Creative Planning's BLRX Position: Q1 2025 in Review
Creative Planning sold out of BioLineRX (BLRX) in Q1 2025, closing a stake of 325 shares — an estimated $2.78K sold.
Creative Planning first reported a position in BLRX in Q4 2015 and held it in 34 quarters. The position peaked at $41K in Q2 2021. 12 funds tracked by Wall St. Rank hold BLRX as of Q1 2025.
- Creative Planning reported no remaining BioLineRX position as of Q1 2025 after selling out during the quarter.
- Creative Planning sold 325 BioLineRX shares in Q1 2025, an estimated $2.78K.
- Creative Planning first reported a position in BioLineRX in Q4 2015 and held it in 34 quarters.
- Creative Planning's BioLineRX position peaked at $41K in Q2 2021.
- 12 funds tracked by Wall St. Rank held BioLineRX as of Q1 2025.
Based on Creative Planning's 13F filing for Q1 2025, filed 15 May 2025.